Results 291 to 300 of about 10,758,011 (382)

DISEASES OF THE CORONARY ARTERIES [PDF]

BMJ, 1928
openaire   +3 more sources

III-10 Clinical studies on arterial occlusive diseases

, 1977
本郷 勉, 山口 寛, 北村 昌之, 石丸 新, 藤生 文平, 尾形 直二郎, 小林 武彦, 百目木 公一, 堀口 康良, 古川 欽一, Masatoshi Takahashi   +10 more
openalex   +2 more sources

From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies

Advanced Science, EarlyView.
This review discusses emerging paradigms in CAR‐T cell therapy for solid tumors, emphasizing strategies to overcome therapeutic barriers through synthetic biology, immune engineering, and combinatorial approaches. It highlights advancements in logic gating, modulation of the immune microenvironment, and innovative cell designs, providing valuable ...
Yang Chen, Ran Ren, Lirong Yan, Yu Zhou, Ruokai Sun, Huicong Song, Hongfei Yan, Yongsheng Li   +7 more
wiley   +1 more source

Ferroptosis: A Key Driver in Atherosclerosis Progression and Arterial Disease. [PDF]

Rev Cardiovasc Med
Elkammash A, Zaki A, Tawfik O, Gouda S.
europepmc   +1 more source

III-5 Experience of omental transplantation in the re-operation of the chronic arterial occlusive diseases

, 1977
星野 俊一, 猪狩 次雄, 鈴木 湧, 板橋 邦宏, 高野 光太郎, 阿部 俊文, 安藤 正樹, Sophie Hamada, 鈴木 俊雄, 本多 憲児   +9 more
openalex   +2 more sources

Engineering Neutrophil Vesicles for Synergistic Protection against Ischemia/Reperfusion Injury after Lung Transplant

Advanced Science, EarlyView.
Engineered neutrophil‐derived vesicles (SOD2‐Fer‐1@CVs) co‐delivering antioxidant and ferroptosis‐inhibitory agents enable inflammation‐targeted, ROS‐responsive therapy for ischemia–reperfusion injury in lung transplantation. Synergizing with ex vivo lung perfusion, this strategy alleviates oxidative stress and inflammation, restores vascular integrity,
Hao‐Xiang Yuan, Yu‐Yun Ye, Pu Shen, Jie Zhang, Qian‐Fang Meng, Ying Chen, Xin Xu, Xuan‐Lin Zhang, Lang Rao, Zhi‐Jin Fan, Jian‐Xing He   +10 more
wiley   +1 more source

Exploring the relationship between ankle strength and endurance factors and the severity and level of ischemia in patients with peripheral arterial disease. [PDF]

J Cardiothorac Surg
Hassani M, Hassabi M, Khodabakhshian S, Javanbakht M, Aliabbar S, Movahedi A, Ghorbani H, Mohebbi M, Movahedi H, Nodoushan MHT, Mirani A.   +10 more
europepmc   +1 more source

The prevalence of peripheral arterial disease in a defined population.

, 1985
Michael H. Criqui, Arnost Fronek, Elizabeth Barrett‐Connor, Melville R. Klauber, S Gabriel, David C. Goodman   +5 more
openalex   +1 more source

Targeted Delivery of CNS‐Specific Hesperidin as a Leptin Sensitizer for Treating Obesity‐Associated Sleep‐Disordered Breathing

Advanced Science, EarlyView.
Hesperidin nanoparticles (HE NPs) effectively combat obesity and sleep‐disordered breathing in mice by enhancing leptin sensitivity. Through suppression of hypothalamic endoplasmic reticulum stress and restoration of leptin signaling, HE NPs promote weight loss and improve breathing during sleep.
Yixuan Wang, Qingyu Zhao, Qingfeng Zhang, Xiaofeng Wu, Xu Liu, Shujuan Wu, Hailing Liu, Beini Zhou, Shiqian Zha, Dong Zhao, Gang Deng, Ke Hu   +11 more
wiley   +1 more source

Current Prognostic Biomarkers for Peripheral Arterial Disease: A Comprehensive Systematic Review of the Literature. [PDF]

Metabolites
Khan H, Girdharry NR, Massin SZ, Abu-Raisi M, Saposnik G, Mamdani M, Qadura M.   +6 more
europepmc   +1 more source